Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion.

@article{Menzies2015ClinicalAO,
  title={Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion.},
  author={Alexander M. Menzies and Iwei Yeh and Thomas Botton and Boris C. Bastian and Richard A. Scolyer and Georgina V. Long},
  journal={Pigment cell & melanoma research},
  year={2015},
  volume={28 5},
  pages={
          607-10
        }
}

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

Kinase Gene Fusions in Melanoma

VIEW 10 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED